Communicating the Risks of Medicines Time to Move Forward

被引：17
作者：
Dal Pan, Gerald J. [1 ]
机构：
[1] US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD 20993 USA
来源：
MEDICAL CARE | 2012年 / 50卷 / 06期
关键词：
D O I：
10.1097/MLR.0b013e31825852f0
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
[No abstract available]
引用
收藏
页码：463 / 465
页数：3
相关论文
共 5 条
[1]  
[Anonymous], 2011, GUID IND WARN PREC C
[2]   Impact of FDA Drug Risk Communications on Health Care Utilization and Health Behaviors A Systematic Review [J].
Dusetzina, Stacie B. ;
Higashi, Ashley S. ;
Dorsey, E. Ray ;
Conti, Rena ;
Huskamp, Haiden A. ;
Zhu, Shu ;
Garfield, Craig F. ;
Alexander, G. Caleb .
MEDICAL CARE, 2012, 50 (06) :466-478
[3]   Failing the public health - Rofecoxib, Merck, and the FDA [J].
Topol, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (17) :1707-1709
[4]  
US Department of Health and Human Services Food and Drug Administration, 2007, GUID IND DRUG SAF CO
[5]  
US Food and Drug Administration, 2012, DRAFT GUID IND DRUG
1